EU/3/04/191

Table of contents

About

Please note that this product was withdrawn from the Community Register of designated Orphan Medicinal Products in July 2015 on request of the sponsor.

On 8 March 2004, orphan designation (EU/3/04/191) was granted by the European Commission to Orfagen, France, for ethanol (96 per cent) (gel for injection) for the treatment of congenital venous malformations.

Key facts

Active substance
Ethanol (96 per cent) (gel for injection)
Disease / condition
Treatment of congenital venous malformations
Date of first decision
09/03/2004
Outcome
Withdrawn
EU designation number
EU/3/04/191

Sponsor's contact details

Orfagen
CRDPF Langlade
3 Avenue Hubert Curien - BP 13562
31035 Toulouse Cedex 1
France
Tel. +33 5345 06459
Fax +33 5345 03457
E-mail: info@orfagen.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating